Secular Trends in the Prevalence of Small Vulnerable Newborns in Japan, 1997-2021

Keisuke Yoshii1, Hibiki Doi1, Mizuho Igarashi1,2

  • 1Division of Endocrinology and Metabolism, National Center for Child Health and Development.

Journal of Epidemiology
|September 7, 2025
PubMed

Insights

The prevalence of small vulnerable newborns (SVNs) in Japan decreased since 2005, primarily due to fewer term small for gestational age (SGA) births. Preterm subgroups remain a concern, indicating a need for improved neonatal care strategies.

Area of Science:

  • Neonatal Health
  • Public Health
  • Epidemiology

Background:

  • The concept of small vulnerable newborns (SVNs) was introduced in 2023 to identify high-risk infants.
  • Global data on SVN prevalence is limited, necessitating regional studies.
  • Understanding SVN trends is crucial for developing effective preventive strategies.

Purpose of the Study:

  • To analyze secular trends in the prevalence of SVNs and their subgroups in Japan.
  • To investigate the prevalence of term small for gestational age (SGA), preterm SGA, and preterm non-SGA infants.
  • To explore potential associations between SVN prevalence and medical resource distribution.

Main Methods:

  • Analysis of Japanese vital statistics data from 1997 to 2021, including livebirths and stillbirths.
  • Assessment of secular trends in the overall SVN population and specific subgroups.
  • Regional analysis to examine the relationship between SVN prevalence and medical resource distribution.

Main Results:

  • A total of 26,172,760 newborns were analyzed.
  • Overall SVN prevalence decreased from 7.8% in 1997 to 7.7% in 2021, peaking at 8.7% in 2005.
  • The decline was driven by reduced term SGA births; preterm SGA and preterm non-SGA rates remained stable.

Conclusions:

  • SVN prevalence in Japan has declined, largely due to a decrease in term SGA births.
  • Persistent high rates in preterm subgroups emphasize the ongoing challenge of prematurity.
  • Targeted interventions are essential to improve neonatal outcomes for vulnerable preterm infants.
Abstract

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Population Growth00:57

Population Growth

Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
27.8K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.0K